How to reach rapid diagnosis in sickle cell disease?

Iranian Journal of Pediatrics

Volumn 20, Issue 1, 2010, Pages 69-74

  Valavi, Ehsan ^a   Ansari, Mohammad Javad Alemzadeh ^a   Zandian, Khodamorad ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Children; Hemoglobin SC disease; Iran; Sickle cell anemia; Sickle cell disease; Thalassemia

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ANEMIA; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; IRAN; MALE; MEAN CORPUSCULAR HEMOGLOBIN; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SICKLE CELL ANEMIA; SPLENOMEGALY;

EID: 77749328144     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (Hb S) allele and sickle cell disease: a HuGE review. Am J Epidemiol. 2000;151(9):839-45.
2. Najmabadi H, Teimourian Sh, Khatibi T, et al. Amplification refractory mutation system (ARMS) and reverse hybridization in the detection of h thalassemia mutations. Arch Irn Med. 2001;4(4):165-70.
3. Habibzadeh F, Yadollahie M, Ayatollahie M, Haghshenass M. The prevalence of sickle cell syndrome in south of Iran. Irn J Med Sci. 1999;24(1):32-4.
4. Merat A, Haghshenass M, Mostafavi pour Z, et al. β-thalassemia in Southwestern Iran. Hemoglobin. 1993;17(5):427-37.
5. Nagel RL, Ranney HM. Genetic epidemiology of structural of the β-globin gene. Semin Hematol. 1990;27(4):342-359 .
6. Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: CR Sriver, AL Beadet, WS Sly, D Valle (Eds.). The Metabolic and Molecular Basis of Inherited Disease. New York ; McGraw Hill. 1995; Pp:3417-84.
7. Kinney TR, Ware RE. Compound heterozygous states. In: SH Embury, RP Hebbel, N Mohandas and MH Steinberg (eds.). Sickle Cell Disease: Basic Principles and Clinical Practice. New York; Raven Press. 1994; Pp: 437-51.
8. Schneider RG. Differentiation of electro phoretically similar hemoglobins such as S, D, G and P; or A2, C, E, and O by electrophoresis of the globin chains. Clin Chem. 1974;20(9):1111-5.
9. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Burtis CA, Ashwood ER (eds). Tietz Textbook of Clinical Chemistry. Philadelphia; Saunders; 1994; Pp:2041-2.
10. Davies SC. Haemoglobinopathies. Paediatrics and child health. 2007;17(8):311-6.
11. Lane PA. Sickle cell disease. Pediatr Clin North Am 1996;43(3):639-64.
12. Bunn FH. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337(11):762-9.
13. Bainbridge R, Higgs DR, Maude GH, Sergeant GR. Clinical presentation of homozygous sickle cell disease. J Pediatr. 1985;106(6):881-5.
14. Williams S, Maude GH, Sergeant GR. Clinical presentation of sickle cell haemoglobin C disease. J Pediatr 1986;109(4):586-9.
15. O'Brien RT, McIntosh S, Aspnes GT, Pearson HA. Prospective study of sickle cell disease in infancy. J Pediatr 1976;89(2):205-10.
16. Leikin SJ, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Pediatrics. 1989;84(3):500-8.
17. Thomas AN, Pattison C, Sergeant GR. Causes of death in sickle cell disease in Jamaica. Br Med J. 1982;285(6342):633-5.
18. Rogers DW, Clark JM, Cupidore L, et al. Early deaths in Jamaican children with sickle cell disease. Br Med J. 1978;1(6126):1515-6.
19. Vichinsky E, Hurt D, Earles A, et al. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81(6):749-55.
20. Githens JH, Lane PA, McCurdy RS, et al. Newborn screening for haemoglobino pathies in Colorado: the first ten years. Am J Dis Child. 1990;144(4):466-70.
21. Vichinsky EP. Comprehensive health care in sickle cell disease: its impact on morbidity and mortality. Semin Haematol. 1991;28 (3):220-6.
22. Pearson H. A neonatal program for sickle cell disease. Adv Pediatr. 1986;33:381-5.
23. Scott RB, Harrison DL. Screening of umbilical cord blood for sickle cell disease: utilization and implementation. Am J Pediatr Haematol Oncol. 1982;4(2):202-5.
24. Odunvbuna ME, Okoloa AA, Rahimy CM. Newborn screening for sickle cell disease in a Nigerian hospital. Public Health. 2008;122 (10):1111-6.
25. Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007;92(7):905-12.
26. Teinberg MH. Management of sickle cell disease. N Engl J Med. 1999; 340 (13): 1021-30.
27. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995;86(2): 776-83.
28. Miller ST, Sleeper LA, Pegelow CH, et al. Predication of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000; 342(2):83-9.
29. Quinn CT, Rogers ZR, and Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103(11):4023-7.
30. Serjeant GR. The blood. In: Sickle Cell Disease, 3rd ed. Oxford: Oxford University Press. 2001; Pp: 113-5.